Validity of Diagnostic Codes and Laboratory Tests to Identify Cholangiocarcinoma and Its Subtypes

By sjmartinez • May 7, 2025

Ferrante ND, Hubbard RA, Weinfurtner K, Mezina AI, Newcomb CW, Furth EE, Bhattacharya D, Njei B, Taddei TH, Singal A, Hoteit MA, Park LS, Kaplan D, Lo Re V 3rd. Validity of Diagnostic Codes and Laboratory Tests to Identify Cholangiocarcinoma and Its Subtypes. Pharmacoepidemiol Drug Saf. 2025 May;34(5):e70154. doi: 10.1002/pds.70154. PMID: 40328444.

Tags: Cholangiocarcinoma, Infectious Diseases, liver cancer, Outcomes, Publications, validation studies, Veterans Administration

SPHERES: innovative registry addressing the new era of neuromyelitis optica spectrum disorders (NMOSD) therapy

Bennett JL, Middaugh N, Yeaman MR, Smith TJ, Behne MK, Crabtree M, McLean RR, Pappas DA, Levy M. SPHERES: innovative registry addressing the new era[...]

A pilot intervention to improve the management of urinary tract infections in outpatient settings

Madaras-Kelly KJ, Nakasone T, Maghari S, Taylor J, Nevers M, Crook J, Brintz B, Braunfeld JB, Goetz MB, Samore M. A pilot intervention to improve[...]

Phylodynamic analysis reveals disparate transmission dynamics of Mycobacterium tuberculosis complex lineages in Botswana

Wang Q, Barilar I, Minin VM, Modongo C, Moonan PK, Finlay A, Boyd R, Oeltmann JE, Molefi TL, Zetola NM, Brewer TF, Niemann S, Shin[...]